BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8844103)

  • 41. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia].
    Tanabe Y; Dan K; Kuriya S; Nomura T
    Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase.
    Ohnishi K; Ohno R; Tomonaga M; Kamada N; Onozawa K; Kuramoto A; Dohy H; Mizoguchi H; Miyawaki S; Tsubaki K
    Blood; 1995 Aug; 86(3):906-16. PubMed ID: 7620184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Fine structure of megakaryocyte precursor cells (promegakaryoblasts) derived from smears and sections of bone marrow tissue in patients with chronic myeloid leukemia and so-called primary osteomyelofibrosis with accompanying thrombocythemia].
    Thiele J; Wagner S; Sander C; Dienemann D; Weuste R; Bertsch HP; Fischer R; Stein H
    Verh Dtsch Ges Pathol; 1990; 74():130-4. PubMed ID: 1708570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Spohr M; Diehl V; Zankovich R; Niederle N; Leder LD
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies.
    Thiele J; Wagner S; Bertsch HP; Wienhold S; Fischer R; Dienemann D; Stein H; Zankovich R
    Pathol Res Pract; 1990 Oct; 186(5):589-96. PubMed ID: 2287586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hematologic response to low dose natural interferon-alpha in a case of CML with myelo-megakaryoblastic crisis].
    Nozaki H; Usui T; Yamauchi K; Kobayashi N; Nakamura Y; Watanabe K; Nagao T; Arimori S
    Rinsho Ketsueki; 1993 Feb; 34(2):232-4. PubMed ID: 8492424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Appearance of chromosomally normal hemopoiesis during busulfan-induced remission in a case of Ph1 positive chronic myelogenous leukemia].
    Takahira H; Ideguchi H; Hirata J; Nishimura J; Nawata H; Shimizu S
    Rinsho Ketsueki; 1989 Feb; 30(2):251-5. PubMed ID: 2746880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Megakaryocytopoiesis in idiopathic thrombocytopenic purpura: a morphometric and immunohistochemical study on bone marrow biopsies with special emphasis on precursor cells.
    Thiele J; von Ammers E; Wagner S; Degel C; Fisher R
    Hematol Pathol; 1991; 5(2):75-82. PubMed ID: 1894584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An immunomorphometric study on megakaryocyte precursor cells in bone marrow tissue from patients with chronic myeloid leukemia (CML).
    Thiele J; Wagner S; Weuste R; Dienemann D; Wienhold S; Zankovich R; Fischer R; Stein H
    Eur J Haematol; 1990 Jan; 44(1):63-70. PubMed ID: 2307221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferating cell nuclear antigen (PCNA) expression of megakaryocytopoiesis in normal human bone marrow and reactive lesions with special emphasis on HIV-myelopathy.
    Thiele J; Titius BR; Kvasnicka HM; Bertsch HP; Erdmann S; Fischer R
    Pathol Res Pract; 1994 Jan; 190(1):42-50. PubMed ID: 7520574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical micromegakaryocytes, promegakaryoblasts and megakaryoblasts: a critical evaluation by immunohistochemistry, cytochemistry and morphometry of bone marrow trephines in chronic myeloid leukemia and myelodysplastic syndromes.
    Thiele J; Titius BR; Kopsidis C; Fischer R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):275-82. PubMed ID: 1279889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Partial and complete disappearance of Ph1 chromosome in two patients with chronic myelogenous leukemia after conventional chemotherapy].
    Kitabayashi A; Miura I; Ito T; Takahashi M; Chubachi A; Niitsu H; Mamiya S; Miura AB
    Rinsho Ketsueki; 1993 Jun; 34(6):733-7. PubMed ID: 8366576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of megakaryocyte ploidy in patients with thrombocytosis.
    Kanz L; Hollen C; Friese P; Burstein SA
    Int J Cell Cloning; 1990 Jul; 8(4):299-306. PubMed ID: 2401806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of IFN-alpha on normal human hematopoiesis: an immunohistochemical and morphometric study on trephine biopsy specimens.
    Thiele J; Wickenhauser C; Neuwirth C; Schulze HJ; Flucke U; Kvasnicka HM; Borchmann P; Krech R; Fischer R
    J Interferon Cytokine Res; 1998 Apr; 18(4):247-53. PubMed ID: 9568727
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon.
    Facchetti F; Tironi A; Marocolo D; Capucci A; Ruggeri G; Bellotti D; Rossi G
    Histopathology; 1997 Jul; 31(1):3-11. PubMed ID: 9253618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group.
    Ohnishi K; Tomonaga M; Kamada N; Onozawa K; Kuramoto A; Dohy H; Mizoguchi H; Miyawaki S; Tsubaki K; Miura Y; Omine M; Kobayashi T; Naoe T; Ohshima T; Hirashima K; Ohtake S; Takahashi I; Morishima Y; Naito K; Asou N; Tanimoto M; Sakuma A; Ohno R
    Leuk Res; 1998 Sep; 22(9):779-86. PubMed ID: 9716008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial.
    Kvasnicka HM; Thiele J; Schmitt-Graeff A; Diehl V; Zankovich R; Niederle N; Leder LD; Schaefer HE
    J Clin Oncol; 2001 Jun; 19(12):2994-3009. PubMed ID: 11408494
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Significance of histologic bone marrow evaluation in diagnosis of chronic granulocytic leukemia. II. Megakaryocytes].
    Komarnicki M; Rasińska M; Woźny T
    Acta Haematol Pol; 1995; 26(2):195-200. PubMed ID: 7653225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.
    Thiele J; Kvasnicka HM; Titius BR; Parpert U; Nebel R; Zankovich R; Dienemann D; Stein H; Diehl V; Fischer R
    Ann Hematol; 1993 Jun; 66(6):291-302. PubMed ID: 8318559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.